Trial NCT01732913

View at ClinicalTrials.gov 
Org. Study IDs: GS-US-313-0124

Last trial update was posted on 2018-11-16

MeSH Interventions

Idelalisib Rituximab

MeSH Conditions

Lymphoma Lymphoma, Non-Hodgkin

Other Conditions

Indolent Non-Hodgkin's Lymphomas

Stopping Reasons

N/A

Limitations And Caveats

Due to the early termination of the study, efficacy data were not available for all participants, and therefore the prespecified analyses were not conducted.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID